PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target.
She S, Wu X, Zheng D, Pei X, Ma J, Sun Y, Zhou J, Nong L, Guo C, Lv P, Song Q, Zheng C, Liang W, Huang S, Li Q, Liu Z, Song Z, Li Y, Zhang Y, Kong W, You H, Xi J, Wang Y.
She S, et al. Among authors: nong l.
J Hepatol. 2020 Mar;72(3):506-518. doi: 10.1016/j.jhep.2019.09.033. Epub 2019 Dec 6.
J Hepatol. 2020.
PMID: 31813573